Literature DB >> 25569290

Mycobacterium africanum is associated with patient ethnicity in Ghana.

Adwoa Asante-Poku1, Dorothy Yeboah-Manu2, Isaac Darko Otchere2, Samuel Y Aboagye2, David Stucki3, Jan Hattendorf4, Sonia Borrell3, Julia Feldmann3, Emelia Danso2, Sebastien Gagneux3.   

Abstract

Mycobacterium africanum is a member of the Mycobacterium tuberculosis complex (MTBC) and an important cause of human tuberculosis in West Africa that is rarely observed elsewhere. Here we genotyped 613 MTBC clinical isolates from Ghana, and searched for associations between the different phylogenetic lineages of MTBC and patient variables. We found that 17.1% (105/613) of the MTBC isolates belonged to M. africanum, with the remaining belonging to M. tuberculosis sensu stricto. No M. bovis was identified in this sample. M. africanum was significantly more common in tuberculosis patients belonging to the Ewe ethnic group (adjusted odds ratio: 3.02; 95% confidence interval: 1.67-5.47, p<0.001). Stratifying our analysis by the two phylogenetic lineages of M. africanum (i.e. MTBC Lineages 5 and 6) revealed that this association was mainly driven by Lineage 5 (also known as M. africanum West Africa 1). Our findings suggest interactions between the genetic diversity of MTBC and human diversity, and offer a possible explanation for the geographical restriction of M. africanum to parts of West Africa.

Entities:  

Mesh:

Year:  2015        PMID: 25569290      PMCID: PMC4287525          DOI: 10.1371/journal.pntd.0003370

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


Introduction

Tuberculosis (TB) remains the leading cause of adult death by a single infectious disease world-wide [1]. Despite the high mortality caused by TB, only 5% to 10% of infected immunocompetent individuals progress from initial infection to active disease [1]. In 2013, an estimated 9.0 million new cases and 1.5 million deaths due to TB occurred; with 30% of the global burden of TB occurring in Africa, an indication of the strong association with HIV/AIDS [1]. TB is caused by a group of closely related bacteria referred to as the Mycobacterium tuberculosis complex (MTBC). MTBC comprises M. tuberculosis sensu stricto and M. africanum which are the main agents of TB in humans, and several variants adapted to various domestic and wild mammal species, including M. bovis, M. caprae, M. microti and M. pinnipedii [2]. MTBC relevant to human disease has been classified into seven main phylogenetic lineages [3]–[4]: Lineages 1 to 4 together with Lineage 7 are collectively known as M. tuberculosis sensu stricto, whereas Lineage 5 and 6 are also known as M. africanum West Africa I and II, respectively [5]. Because MTBC harbours limited genetic diversity compared to other bacteria [6], for a long time the assumption was that host and environmental factors were the only relevant determinants driving the course of TB infection. However, recent studies have challenged this dogma. Indeed, experimental infection models have shown that MTBC strains differ in virulence and immunogenicity [7], and epidemiological studies have demonstrated that in addition to host and environmental factors, strain diversity contributes to the variable outcome of TB infection and disease in clinical settings [8]. The MTBC lineages adapted to humans exhibit a strong phylogeographic population structure [4]. This together with the finding that the MTBC most likely originated in Africa and accompanied human migrations over millennia [9] has led to the proposal that the different lineages of human-associated MTBC might have locally adapted to different human populations [10]. Support for this notion comes from the observation that in metropolitan settings, MTBC lineages tend to transmit preferentially among sympatric (as opposed to allopatric) host populations [11], and that this sympatric host-pathogen association is perturbed by HIV co-infection [12]. Previous work showed that in Ghana, human TB is caused by six out of the seven MTBC lineages, with 20% of all cases attributed to Lineages 5 and 6 [13] (i.e. M. africanum West-Africa I and West-Africa II, respectively). M. africanum is highly restricted to West-Africa for reasons unknown [5], [10]. One possibility could be that M. africanum has adapted to particular human populations in that region of the world. To address this possibility, we performed a retrospective molecular epidemiological study of MTBC in Southern Ghana. We combined bacterial genotyping with detailed demographic and epidemiological patient data and sought for associations between host factors and the main MTBC lineages prevailing in Ghana.

Methods

Ethics statement

All study protocols including oral and written consent format used for this study were approved by the Institutional Review Board (IRB) of the Noguchi Memorial Institute for Medical Research, Legon-Ghana (NMIMR; Federal wide Assurance number FWA00001824) and from the Ethikkommission Beider Basel (EKBB) in Basel, Switzerland. The standard procedure for sampling as outlined by the National Tuberculosis Program (NTP) for the routine management of TB in Ghana was used in the study. Written (in the case of literate participants) or oral (for illiterates) informed consent was sought from all participants before inclusion in the study. For minors (below sixteen years of age) consent was sought from their parents/guardians before enrolment into the study. In the case of minors between sixteen and eighteen years, in addition to parental consent, assent was sought from them before enrolment into the study. As per the guidelines of the IRB of NMIMR, information confidentiality was strictly adhered to. In addition, objectives and benefits of the study were explained to all participants.

Study setting and patients' characteristics

The study was conducted from July 2007 to August 2011. All patients were diagnosed as sputum Acid-Fast-Bacilli-positive pulmonary TB cases by microscopy. The patients were recruited before treatment initiation from five main health facilities; Korle-Bu Teaching Hospital in the Greater Accra region, Agona Swedru Government Municipal Hospital, Winneba Government Hospital, St Gregory Catholic Clinic from the Central Region and Effia-Nkwanta Regional Hospital from Western Region of Ghana. Information on age, sex, nationality, ethnicity, employment status, previous history of TB, crowding, substance abuse and duration of symptoms were obtained from the patients with a structured questionnaire. Patients with missing information or culture-negative status were excluded from analysis. Ethnicity was classified in line with Ghana demographic data 2010 [14]. Patient origin was defined by place of residence.

Isolation of mycobacterial species and genotyping

Sputum samples obtained were decontaminated using 5% oxalic acid [15] and inoculated on two pairs of Lowenstein Jensen (LJ) slants; one supplemented with 0.4% sodium pyruvate to enhance the isolation of M. africanum and M. bovis, and the other with glycerol for the growth of M. tuberculosis sensu stricto. The cultures were incubated at 37°C and were read weekly for growth for a maximal duration of 16 weeks. MTBC strains were identified by detection of insertion sequence IS6110 as previously described [16]. Classification into the main phylogenetic lineages of MTBC was achieved by large sequence polymorphism typing identifying regions of difference (RD) [2] in a stepwise manner. Firstly, all isolates were screened for RD9. RD9-undeleted strains were further sub-typed for the “Cameroon” strain family (known to be most dominant Lineage 4 sub-lineage in Ghana) by screening for deletion of RD726 [11]. Isolates identified as RD9-deleted were subsequently sub-typed for Lineage 5 and 6 using RD711 and RD702 flanking primers, respectively. All lineages identified were confirmed by TaqMan real time PCR (TaqMan, Applied Bio systems, USA) using probes targeting lineage-specific SNPs as reported [17].

Spoligotyping

All MTBC isolates were typed by spoligotyping [18]. This was performed according to the manufacturer's instructions, using commercially available kits (Isogen Bioscience BV Maarssen, The Netherlands). Spoligotyping patterns were defined according to SITVITWEB database [19] (http://www.pasteur-guadeloupe.fr:8081/SITVIT_ONLINE). SITVITWEB assigned shared types numbers were used whenever a spoligotyping pattern was found in the database while families and subfamilies were assigned based on the MIRU-VNTRplus database (http://www. miru-vntrplus.org) [20]. Shared types were defined as patterns common to at least two or more isolates. All patterns that could not be assigned were considered orphan spoligotypes.

Data entry, management and analysis

Information from the structured questionnaire was double entered using Microsoft Access and validated to remove duplicates and data entry inconsistencies. Multivariable logistic regression models were used to compare patient characteristics associated with M. africanum compared to M. tuberculosis sensu stricto. All statistical analyses were performed in STATA 10.1 (Stata Corp., College Station, TX, USA).

Results

Tuberculosis patients and their characteristics

A total of 622 TB patients were included in this study. Age of patients ranged from 8 to 77 years with a median age of 35 years (Table 1). Overall, 208/622 (33.4%) were females with median age of 33 years; the remaining 414 (66.6%) were males with a median age of 36. Twenty-nine out of the 622 patients (4.6%) were children (age<16 years). Most patients originated from Greater Accra Region (325 cases, 52.3%), followed by 268 cases (43.1%) from Central Region with the remaining twenty-nine patients (4.6%) from Western Region of Ghana. Out of the 622 patients, 596 (95.8%) were Ghanaians, 21 (3.3%) were Liberians, 2 Togolese (0.3%) and 1 (0.2%) each of Nigerian, Ivorian and Gambian origin, respectively. Most of the patients were of Akan ethnicity (N = 427, 68.7%), followed by Ga (N = 104, 16.7%), Ewe (N = 71, 11.4%) with the remaining ethnicities accounting for 3.2% (N = 20). In terms of education, 436 patients (70.1%) were illiterates, 44 (7.1%) primary education, 132 (21.2%) had up to secondary education, and the remaining 10 (1.6%) tertiary education. More than half of the study population (N = 324, 52%) consumed alcohol on a regular basis, while only 44 (7%) smoked.
Table 1

Characteristics of patients included in the study.

VariableN = 622%
Sex
Male41466.6
Female20833.4
Age
Years 08–2512420.0
Years 26–4028245.3
Years 41–7721634.7
Residency
Rural11718.8
Urban50581.2
Region
Greater Accra32552.3
Central26843.1
Western294.6
Ethnicity
Akan42768.7
Ewe7111.4
Ga10416.7
Other203.2
Religion
Christian56490.7
Muslim375.9
Pagan213.4
Level of Education
No education43670.1
Primary school447.1
Secondary13221.2
Tertiary101.6
Alcohol Intake
Yes32452.1
No29847.9
Smoking Status
Smokers447.1
Non smokers57892.9
Crowding(1-4 pers) 19531.4
(>5 pers)42768.6
Occupation
Farmer457.2
Others57792.8

Prevalence of MTBC lineages and sub-lineages

MTBC isolates were obtained from all 622 TB patients. Upon genotyping, 9 of these (1.4%) produced ambiguous results and were thus excluded from further analysis. Hence, a total of 613 isolates were used for further analysis. Based on LSP and SNP typing, we identified six out of the seven human-associated MTBC lineages in our study sample (Table 2). The dominant lineages were Lineage 4 with 483 cases (78.8%), Lineage 5 (N = 86, 14.0%) and Lineage 6 (N = 19, 3.1%). Eleven isolates (1.8%) belonged to Lineage 1, 10 to Lineage 2 (includes Beijing; 1.6%), and the remaining 4 isolates to Lineage 3 (0.7%). Among the 483 Lineage 4 isolates, 313/483 (65.0%) belonged to the sub-lineage of Lineage 4 known as the ‘Cameroon family’. No M. bovis was identified in our sample.
Table 2

Genotyping profiles of 613 M. tuberculosis complex isolates from Ghana.

SpeciesSNPRD9RD726RD711RD702Spoligotyping profileSub-lineagea SITNo%
MTBssL1UndelUndelNDND▪□□▪▪▪▪□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪□▪▪▪▪▪▪▪▪▪▪EAI34081.3
MTBssL1UndelUndelNDND▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪□□▪▪▪▪▪□▪▪▪EAI10.2
MTBssL1UndelUndelNDND▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪□▪▪▪▪▪▪▪▪▪▪EAI34210.2
MTBssL1UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪□▪▪▪▪▪▪▪▪▪▪EAI23610.2
MTBssL2UndelUndelNDND□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪Beijing1101.6
MTBssL3UndelUndelNDND▪□□▪□□□□□□□□▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪DEHLI/CAS20.3
MTBssL3UndelUndelNDND▪▪▪□□□□▪▪▪▪▪▪▪□▪▪▪▪▪▪□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪DEHLI/CAS10.2
MTBssL3UndelDelNDND▪▪▪□□□□▪□▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪DEHLI/CAS109210.2
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Cameroon6122636.8
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪□□▪▪□□□□▪▪▪▪▪▪▪Cameroon772203.2
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Cameroon11571.1
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪▪▪□▪▪Cameroon83830.4
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Cameroon264.2
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪▪□▪▪▪Cameroon10.2
MTBssL4UndelDelNDND▪▪▪▪▪▪▪□▪▪▪▪▪▪□▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪□▪▪□▪Cameroon10.2
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪□▪□▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Cameroon20.3
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Cameroon114110.2
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪▪□▪▪▪Cameroon40310.2
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Cameroon20.3
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪□□□▪▪▪□□▪▪□□□□▪▪▪▪▪▪▪Cameroon20.3
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪□□□□□▪▪▪▪▪□□□□▪▪▪▪▪▪▪Cameroon30.4
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪□▪▪□▪Cameroon20.3
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪□▪▪▪□□□□▪▪▪▪▪▪▪Cameroon10.2
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□▪▪▪▪□□□□▪▪▪▪▪▪▪Cameroon10.2
MTBssL4UndelDelNDND▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪□□▪▪□□□□▪▪▪▪▪▪▪Cameroon10.2
MTBssL4UndelDelNDND▪▪▪□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪Cameroon20.3
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪□□□□▪▪□▪▪□▪Cameroon30.4
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪□▪▪▪□□□□▪▪▪▪▪▪▪Cameroon10.2
MTBssL4UndelDelNDND▪□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Cameroon20.3
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□▪▪▪□□□□▪▪▪▪▪▪▪Cameroon30.4
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪▪□□▪□▪Cameroon10.2
MTBssL4UndelDelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪□□□□▪□□□□□□Cameroon10.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Ghana53264.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪□□▪▪▪▪Ghana6540.7
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Ghana50471.1
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Ghana118121.9
MTBssL4UndelUndelNDND▪□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Ghana80410.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪□□□□▪▪▪▪▪▪▪Ghana46240.7
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Ghana4410.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Ghana86121.9
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪□□□□▪▪▪▪▪▪▪Ghana16710.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Ghana37310.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Ghana39310.2
MTBssL4UndelUndelNDND□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪Ghana27210.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪□▪▪□▪Ghana40.7
MTBssL4UndelUndelNDND▪□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□▪□□□□▪▪▪▪▪▪▪Haarlem165240.7
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□▪▪▪▪▪▪▪Haarlem149860.9
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪□□□□▪▪▪▪▪▪▪Haarlem50152.4
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪□□□□□□▪□□□□▪▪▪▪▪▪▪Haarlem4520.3
MTBssL4UndelUndelNDND▪□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪□□□□▪▪▪▪▪▪▪Haarlem65530.4
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□▪□□□□▪▪▪▪▪▪▪Haarlem4720.3
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□▪□□□□▪▪▪□▪▪▪Haarlem6220.3
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□▪▪□▪▪□▪Haarlem20.3
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□▪□□□□▪▪▪□□▪▪Haarlem10.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□▪▪□▪▪▪□□□□▪▪▪▪▪▪▪LAM30610.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪□□□□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪LAM10.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪LAM4220.3
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪LAM3310.2
MTBssL4UndelUndelNDND▪▪▪□□□□□□□□▪▪▪▪▪▪□▪▪□□□□▪▪▪▪▪▪▪▪□□□□▪▪□▪▪▪▪7071.1
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪□□□□▪▪□□□□▪Uganda I20.3
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪□▪▪▪Uganda I5240.7
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪□□□□▪Uganda I24410.20.4
MTBssL4UndelUndelNDND▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪□▪▪▪Uganda I8483
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪□□▪▪Uganda I20.3
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪□□▪□▪Uganda I7810.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪□□□□▪▪□□□□▪Uganda I10.2
MTBssL4UndelUndelNDND□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪□□□□▪▪□□□□▪Uganda I12510.2
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪□□□□Uganda II5120.3
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪□□▪□□▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪□□□□▪▪□□▪□▪Uganda II20.3
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪□□□□□□▪▪▪▪▪□▪▪▪▪▪▪▪▪□▪□□□□▪▪▪▪▪▪▪Uganda II30.4
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪S122320.3
MTBssL4UndelUndelNDND▪□▪▪▪▪▪□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪S121120.3
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪X11920.3
MTBssL4UndelUndelNDND▪▪▪□□□□□□□□□▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪□□□□20071.1
MTBssL4UndelUndelNDND▪▪□▪▪▪▪□□□□□▪□▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪20.3
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪□□□□▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪20.3
MTBssL4UndelUndelNDND▪□□▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪□□□□▪▪▪▪▪▪▪10.2
MTBssL4UndelUndelNDND▪▪▪□□□□□□□▪□▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪10.2
MTBssL4UndelUndelNDND▪▪▪□□□□□□□▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪□□□□40.7
MTBssL4UndelUndelNDND▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪10.2
MafricL5DelNDDelUndel▪▪▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA I331172.8
MafricL5DelNDDelUndel▪□▪▪▪▪▪▪□□□□□▪▪□▪▪▪▪▪□□▪□▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA I10.2
MafricL5DelNDDelUndel▪□▪▪▪▪▪▪□□□□□▪▪□▪▪▪▪▪□□□□□▪□□□□□□□□□□□□□▪▪▪WA I10.2
MafricL5DelNDDelUndel▪▪▪▪▪▪▪▪□□□□□□□▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA I10.2
MafricL5DelNDDelUndel▪□▪▪▪▪▪▪□□□□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA I319162.6
MafricL5DelNDDelUndel▪▪▪▪▪▪▪▪□□□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA I43891.5
MafricL5DelNDDelUndel▪□▪▪▪▪▪▪□□□□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA I86010.2
MafricL5DelNDDelUndel▪▪▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪▪□□□□□▪□□□□□□□□□□□□□▪▪▪WA I159220.3
MafricL5DelNDDelUndel▪▪▪▪▪▪▪□□□□□▪▪▪▪□□□□□□□□▪▪□□□□□▪▪▪▪▪□□□▪▪▪▪WA I10.2
MafricL5DelNDDelUndel▪▪▪▪▪▪▪▪▪□▪▪▪▪▪□▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪□▪WA I10.2
MafricL5DelNDDelUndel▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪□□▪□▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪□▪WA I10.2
MafricL5DelNDDelUndel▪□▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA I30.4
MafricL5DelNDDelUndel▪▪▪▪▪▪▪▪□□□□□▪▪□▪▪▪▪□□□□□□▪□▪▪▪□□□▪▪□□□□▪□▪WA I10.2

Sub-lineage as defined by the MIRU-VNTRplus database, Undel = not deleted, Del = deleted, ND = Not done.

Sub-lineage as defined by the MIRU-VNTRplus database, Undel = not deleted, Del = deleted, ND = Not done. All isolates were further sub-typed using spoligotyping (Table 2). We detected a total of 117 spoligotypes, 485/613 isolates (79%) had previously defined shared type number (SIT). The remaining 128 isolates could not be defined by the SITVIT database and thus were defined as ‘orphan’. In addition to Cameroon sub-lineage, seven additional sub-lineages were identified among Lineage 4 based on spoligotyping; Ghana (N = 75, 15.5%), Haarlem (N = 37, 7.7%), Uganda I (N = 15, 3.1%), Uganda II (N = 7, 1.4%), LAM (N = 5, 1.0%), S (N = 4 (0.8%), and X (N = 2, 0.4%).

Association between MTBC lineages and patient characteristics

Table 3 illustrates the association of socio demographic and behavioural factors with the main MTBC lineages present in our study sample. Using multivariable logistic regression model analysis, we found that individuals of Ewe ethnicity were significantly more likely to present with TB caused by M. africanum as opposed to M. tuberculosis sensu stricto irrespective of their place of residence (adjusted odds ratio (adjOR) = 3.02; 95% confidence interval (CI): 1.67–5.47, P<0.001) (Table 3, S1 Fig.). This association was independent from other risk factors. Moreover, we found TB caused by M. africanum to be associated with smoking (adjOR = 2.02; 95% CI: 0.95–4.27) when compared to M. tuberculosis sensu stricto. However, this association was only borderline statistically significant (P = 0.07). No significant associations between MTBC lineages and other patient variables were found. Because M. africanum comprises two phylogenetic distinct lineages (i.e. MTBC Lineages 5 and 6), we performed a stratified analysis by lineage. Using multivariate logistic regression model analysis, we observed a significant association between Ewe ethnicity and Lineage 5 (adjOR)  = 2.79; 95% CI: 1.47–5.29, P<0.001). This association was independent from other risk factors (Table 4). Interestingly, based on univariate analysis, we also saw an association between Ewe ethnicity and Lineage 6 (adjOR = 4.03; 95% CI: 1.33–10.85). However, because of the limited number of Lineage 6 isolates (n = 18) multivariate analyses could not be performed to confirm the independence of this association.
Table 3

Risk factors for TB caused by M. africanum compared to M. tuberculosis sensu stricto.

Risk factor %(n) Mafr %(n) MTBss OR (95%CI) adjOR (95%CI)a
(n = 102)(n = 511)
Sex (male)68% (69)66% (338)0.93 (0.59–1.47)
Age category
years 08–2517% (17)21% (105)reference
years 26–4053% (54)44% (223)1.50 (0.83–2.70)
years 41–7730% (31)36% (183)1.05 (0.55–1.98)
Rural residency20% (20)18% (93)1.10 (0.64–1.88)
Region
Accra55% (56)52% (267)referencereference
Central42% (43)43% (218)0.94 (0.61–1.45)0.97 (0.60–1.56)
Western3% (3)5% (26)0.55 (0.16–1.88)0.44 (0.12–1.63)
Ethnicity
Akan58% (59)71% (359)referencereference
Ewe23% (23)9% (48)2.91 (1.65–5.14)* 3.02 (1.67–5.47)*
Ga15% (15)17% (89)1.03 (0.56–1.89)0.97 (0.51–1.83)
other5% (5)3% (15)2.03 (0.71–5.79)2.35 (0.77–7.13)
Religion
Christian92% (94)90% (462)reference
Muslim7% (7)6% (29)1.18 (0.50–2.79)
Pagan1% (1)4% (20)0.25 (0.03–1.85)
Educational level
No education74% (75)70% (356)reference
Primary school6% (6)7% (38)0.75 (0.30–1.83)
Secondary21% (21)23% (117)0.85 (0.50–1.44)
Alcohol57% (58)52% (263)1.23 (0.81–1.90)
Smoking11% (11)6% (32)1.81 (0.88–3.72)2.02 (0.95–4.27)
Crowding (>5 pers)b 63% (64)70% (359)0.71 (0.45–1.10)
Occupation farmer9% (9)7% (35)1.32 (0.61–2.83)
Table 4

Risk factors for Risk factor for TB caused by Lineage 5 compared to M. tuberculosis sensu stricto.

Risk factor%(n) Lineage 5%(n) MTBssOR (95%CI)adjOR (95%CI)a
(n = 84)(n = 511)
Sex (male)59% (58)66% (338)1.41 (0.69–1.88)
Age category
years 08–2518% (15)21% (105)reference
years 26–4051% (43)43% (223)1.35 (0.72–2.54)
years 41–7731% (26)36% (183)0.99 (0.5–1.96)
Rural residency19% (16)18% (93)1.06 (0.59–1.91)
Region
Accra54% (45)52% (267)reference
Central42% (36)43% (218)0.98 (0.61–1.57)
Western4% (3)5% (26)0.68 (0.2–2.36)
Ethnicity
Akan61% (51)70% (359)referencereference
Ewe20% (17)9% (48)2.49 (1.33–4.66)**2.79 (1.47–5.29)**
Ga14% (12)17% (89)0.95 (0.49–1.86)0.85 (0.43–1.69)
other5% (4)3% (15)1.88 (0.6–5.88)1.64 (0.53–5.34)
Religion
Christian93% (78)90% (462)reference
Muslim6% (5)6% (29)1.02 (0.38–2.72)
Pagan1% (1)4% (20)0.29 (0.04–2.24)
Educational level
No education70% (59)70% (356)reference
Primary school7% (6)7% (38)0.95 (0.39–2.35)
Secondary +23% (19)23% (117)0.98 (0.56–1.71)
Alcohol62% (52)52% (263)1.53 (0.95–2.45) 1.62 (0.99–2.68)
Smoking11% (9)6% (32)1.8 (0.82–3.91)1.54 (0.68–3.50)
Crowding (>5 pers)c 63% (53)70% (359)0.72 (0.44–1.16)
Occupation farmer11% (9)7% (35)0.61 (0.28–1.32)0.64 (0.29–1.45)

Discussion

Our retrospective molecular epidemiological investigation of MTBC clinical isolates from Southern Ghana revealed that i) the Cameroon sub-lineage of Lineage 4 is the dominant cause of human TB in this region, ii) 17.1% of human TB is caused by M. africanum, iii) TB patients infected with M. africanum were more likely to smoke, and iv) to belong to the Ewe ethnic group. Our finding that the Cameroon sub-lineage causes 65% of human TB in Ghana confirms our previous report from Ghana [13], and is in agreement with findings from neighbouring countries. In particular, the Cameroon sub-lineage was previously found to cause 40% of human TB in Cameroon [21], 45% in Nigeria [22] and 33% in Chad [23]. The reasons for the success of this sub-lineage in this region of Africa are unclear but could be due to a founder effect and/or particularly high fitness in the corresponding patient populations. Similarly, other successful sub-lineages of Lineage 4 have been observed in other regions of Africa, including Uganda [24] and Zimbabwe [25]. We found that in Ghana, M. africanum still accounts for 17.1% of all human TB, which is similar to the prevalence we reported several years ago [13]. This is in contrast to a study in Cameroon [21] that indicated a sharp decrease in TB caused by M. africanum during the last decades. A potential explanation for the decline of M. africanum in some West African countries includes possible out-competition by M. tuberculosis, as M. africanum has been associated with reduced virulence in animal models [26]–[27], and a longer latency and a slower rate of progression to active disease in humans [28]. Of note, our finding that smoking was associated with infection by M. africanum as opposed to M. tuberculosis sensu stricto is consistent with the notion that M. africanum might be less virulent in immunocompetent hosts [7]. This notion is also supported by a previous study in the Gambia reporting a significant association between M. africanum West Africa II and HIV co-infection [29]. However, no such association was found between M. africanum West Africa I and II in Ghana [30]. Because information on HIV status was not available for the present study, we could not explore this question here. Taken together, there is a need for further investigation to ascertain why M. africanum is declining in some regions of West Africa, but not in Ghana, and whether this phenomenon can be attributed to differences in virulence and/or other factors. One reason for why the prevalence of M. africanum might be more stable in Ghana than in some other countries is that this bacterial lineage might be particularly well adapted to (some) human populations in Ghana. Our finding that M. africanum was independently associated with Ewe ethnicity supports this possibility. Moreover, this association was largely driven by Lineage 5, and not the result of a single outbreak as the spoligotyping patterns among M. africanum isolates from Ewe patients were diverse (Table 5). From available data, we know that M. africanum, in particular Lineage 5 is prevalent in countries around the Gulf of Guinea [13], [31], and particularly frequent in Benin and Ghana [13], [32], two countries with large Ewe populations [33]. The Ewe speaking ethnic group traditionally forms part of the Gbe language family which includes the Fons of Benin, the Aja of Togo and the Phla-phera of western Nigeria [33], [34]. Although the Ewe, Fons, Aja and phla-phera are different dialects of the same Gbe language family, members of theses individual groups are interrelated [33], [34]. Together they constitute the indigenous inhabitants of coastal West Africa.
Table 5

Spoligotyping profiles of M. africanum isolates from patients of Ewe ethnicity.

SpeciesSNPRD726RD711RD702Spoligotyping profileSub-lineagea SITNo%
MafricL5NDDelUndel▪▪▪▪▪▪▪□□□□□▪▪▪▪□□□□□□□□▪▪□□□□□▪▪▪▪▪□□□▪▪▪▪WA I28.8
MafricL5NDDelUndel▪▪▪▪▪▪▪□□□□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA I438521.7
MafricL5NDDelUndel▪▪▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA I331730.4
MafricL5NDDelUndel▪□▪▪▪▪▪▪□□□□□▪▪□▪▪▪▪▪□□▪□▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA IOrphan14.3
MafricL5NDDelUndel▪□▪▪▪▪▪▪□□□□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪WA I31928.8
MafricL5NDDelUndel▪▪▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪▪□□□□□▪□□□□□□□□□□□□□▪▪▪WA I159214.3
MafricL6NDUndelDel▪▪▪▪▪▪□□□▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪WA 232428.8
MafricL6NDUndelDel▪▪▪▪▪▪□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪WA 218114.3
MafricL6NDUndelDel▪□▪▪▪▪□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪WA 231814.3
MafricL6NDUndelDel▪▪▪▪▪▪▪▪▪□▪▪▪□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪WA 2Orphan14.3

Sub-lineage as defined by the MIRU-VNTRplus database, Undel = not deleted, Del = deleted, ND = Not done.

Sub-lineage as defined by the MIRU-VNTRplus database, Undel = not deleted, Del = deleted, ND = Not done. Associations between particular MTBC lineages and human ethnicities have been observed before. For example, in San Francisco, Lineage 1, 2 and 4 were strongly associated with Filipino, Chinese, and “white” ethnicities, respectively [11]. More recently, Hui ethnicity was found to be associated with the Beijing family of MTBC in China [35]. While social “cohesion” is likely to restrict intermingling between individuals belonging to different ethnic groups and thus transmission of MTBC between these groups, biological factors could also play a role in the association between different MTBC genotypes and human populations. Self-defined ethnicity has been shown to be a reliable proxy for human ancestry [36], and human genetic diversity has been linked to an increased or reduced susceptibility to TB [37]. Importantly, recent studies indicate that human genetic susceptibility to TB is further influenced by the MTBC genotype [10]. In particular, studies have reported human genetic polymorphisms that influence the susceptibility to TB caused by M. africanum but not M. tuberculosis sensu stricto or vice versa [38]. For example, a study performed in Ghana reported a human polymorphism in 5-lipoxygenase (ALOX5) associated with increased TB risk [39]. Stratification by MTBC lineage revealed that this association was mainly driven by M. africanum indicating that this human polymorphism increases the risk of TB in a MTBC lineage-specific matter. ALOX5 is involved in the synthesis of leukotrienes and lipoxins, which are important mediators of the inflammatory response [39]. Conversely, a human polymorphism reported recently in the Mannose Binding Lectin (MBL) was associated with protection against TB caused by M. africanum but not M. tuberculosis sensu stricto [40]. Moreover, this latter study also found that M. africanum bound human recombinant MBL more efficiently, perhaps leading to an improved uptake of M. africanum by macrophages and selection of deficient MBL variants among human populations exposed to M. africanum [40]. Our study has several limitations. First, data on HIV co-infection was not available. This might have influenced our results on the patient characteristics associated with M. africanum. Secondly, this study was not population-based as patients were recruited only at three government hospitals. Hence, some degree of selection bias cannot be excluded. In conclusion, our study provides novel insights into the interaction between environmental, host and pathogen variability in human TB. In particular, the observed association between M. africanum and Ewe patient ethnicity suggests a possible explanation for the geographical restriction of M. africanum to parts of West Africa. Our findings also highlight the need to consider this variability in the development of new tools and strategies to control TB. Geographical distribution of lineages by patient ethnic group. Each dot stands for a single isolate and patient place of residence. (PDF) Click here for additional data file. STROBE checklist. (DOCX) Click here for additional data file.
  36 in total

1.  Genetic structure of human populations.

Authors:  Noah A Rosenberg; Jonathan K Pritchard; James L Weber; Howard M Cann; Kenneth K Kidd; Lev A Zhivotovsky; Marcus W Feldman
Journal:  Science       Date:  2002-12-20       Impact factor: 47.728

2.  Mycobacterium africanum: a new opportunistic pathogen in HIV infection?

Authors:  Bouke C de Jong; Philip C Hill; Roger H Brookes; Jacob K Otu; Kevin L Peterson; Peter M Small; Richard A Adegbola
Journal:  AIDS       Date:  2005-10-14       Impact factor: 4.177

Review 3.  Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens.

Authors:  Mark Achtman
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

4.  Variable host-pathogen compatibility in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Kathryn DeRiemer; Tran Van; Midori Kato-Maeda; Bouke C de Jong; Sujatha Narayanan; Mark Nicol; Stefan Niemann; Kristin Kremer; M Cristina Gutierrez; Markus Hilty; Philip C Hopewell; Peter M Small
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

5.  A molecular epidemiological and genetic diversity study of tuberculosis in Ibadan, Nnewi and Abuja, Nigeria.

Authors:  Lovett Lawson; Jian Zhang; Michel K Gomgnimbou; Saddiq T Abdurrahman; Stéphanie Le Moullec; Fatima Mohamed; Gertrude N Uzoewulu; Olumide M Sogaolu; Khye Seng Goh; Nnamdi Emenyonu; Guislaine Refrégier; Luis E Cuevas; Christophe Sola
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

6.  Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans.

Authors:  Iñaki Comas; Mireia Coscolla; Tao Luo; Sonia Borrell; Kathryn E Holt; Midori Kato-Maeda; Julian Parkhill; Bijaya Malla; Stefan Berg; Guy Thwaites; Dorothy Yeboah-Manu; Graham Bothamley; Jian Mei; Lanhai Wei; Stephen Bentley; Simon R Harris; Stefan Niemann; Roland Diel; Abraham Aseffa; Qian Gao; Douglas Young; Sebastien Gagneux
Journal:  Nat Genet       Date:  2013-09-01       Impact factor: 38.330

7.  The first phylogeographic population structure and analysis of transmission dynamics of M. africanum West African 1--combining molecular data from Benin, Nigeria and Sierra Leone.

Authors:  Florian Gehre; Martin Antonio; Frank Faïhun; Mathieu Odoun; Cecile Uwizeye; Pim de Rijk; Bouke C de Jong; Dissou Affolabi
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

8.  Two new rapid SNP-typing methods for classifying Mycobacterium tuberculosis complex into the main phylogenetic lineages.

Authors:  David Stucki; Bijaya Malla; Simon Hostettler; Thembela Huna; Julia Feldmann; Dorothy Yeboah-Manu; Sonia Borrell; Lukas Fenner; Iñaki Comas; Mireia Coscollà; Sebastien Gagneux
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

9.  HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis.

Authors:  Lukas Fenner; Matthias Egger; Thomas Bodmer; Hansjakob Furrer; Marie Ballif; Manuel Battegay; Peter Helbling; Jan Fehr; Thomas Gsponer; Hans L Rieder; Marcel Zwahlen; Matthias Hoffmann; Enos Bernasconi; Matthias Cavassini; Alexandra Calmy; Marisa Dolina; Reno Frei; Jean-Paul Janssens; Sonia Borrell; David Stucki; Jacques Schrenzel; Erik C Böttger; Sebastien Gagneux
Journal:  PLoS Genet       Date:  2013-03-07       Impact factor: 5.917

10.  Long-term dominance of Mycobacterium tuberculosis Uganda family in peri-urban Kampala-Uganda is not associated with cavitary disease.

Authors:  Eddie M Wampande; Ezekiel Mupere; Sara M Debanne; Benon B Asiimwe; Mary Nsereko; Harriet Mayanja; Kathleen Eisenach; Gilla Kaplan; Henry W Boom; Sebastien Gagneux; Moses L Joloba
Journal:  BMC Infect Dis       Date:  2013-10-17       Impact factor: 3.090

View more
  31 in total

Review 1.  Ecology and evolution of Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux
Journal:  Nat Rev Microbiol       Date:  2018-02-19       Impact factor: 60.633

2.  Evaluation of GenoType MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana.

Authors:  Adwoa Asante-Poku; Isaac Darko Otchere; Emelia Danso; David Delali Mensah; Frank Bonsu; Sebastien Gagneux; Dorothy Yeboah-Manu
Journal:  Int J Tuberc Lung Dis       Date:  2015-08       Impact factor: 2.373

3.  Correlates between models of virulence for Mycobacterium tuberculosis among isolates of the Central Asian lineage: a case for lysozyme resistance testing?

Authors:  Claire Pardieu; Nicola Casali; Simon O Clark; Richard Hooper; Ann Williams; Preya Velji; Ximena Gonzalo; Francis Drobniewski
Journal:  Infect Immun       Date:  2015-03-16       Impact factor: 3.441

4.  Model-based integration of genomics and metabolomics reveals SNP functionality in Mycobacterium tuberculosis.

Authors:  Ove Øyås; Sonia Borrell; Andrej Trauner; Michael Zimmermann; Julia Feldmann; Thomas Liphardt; Sebastien Gagneux; Jörg Stelling; Uwe Sauer; Mattia Zampieri
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-30       Impact factor: 11.205

Review 5.  Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy.

Authors:  Yuan-qiang Zheng; Youssef W Naguib; Yixuan Dong; Yan-chun Shi; Shorgan Bou; Zhengrong Cui
Journal:  Expert Rev Vaccines       Date:  2015       Impact factor: 5.217

6.  Analysis of Mycobacterium africanum in the last 17 years in Aragon identifies a specific location of IS6110 in Lineage 6.

Authors:  Jessica Comín; María Luisa Monforte; Sofía Samper; Isabel Otal
Journal:  Sci Rep       Date:  2021-05-14       Impact factor: 4.379

7.  Genotypic and phenotypic diversity of Mycobacterium tuberculosis complex genotypes prevalent in West Africa.

Authors:  Stephen Osei-Wusu; Isaac Darko Otchere; Portia Morgan; Abdul Basit Musah; Ishaque Mintah Siam; Diana Asandem; Theophilus Afum; Prince Asare; Adwoa Asante-Poku; Kwadwo Asamoah Kusi; Sebastien Gagneux; Dorothy Yeboah-Manu
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

8.  Whole Genome Sequencing of Mycobacterium africanum Strains from Mali Provides Insights into the Mechanisms of Geographic Restriction.

Authors:  Kathryn Winglee; Abigail Manson McGuire; Mamoudou Maiga; Thomas Abeel; Terrance Shea; Christopher A Desjardins; Bassirou Diarra; Bocar Baya; Moumine Sanogo; Souleymane Diallo; Ashlee M Earl; William R Bishai
Journal:  PLoS Negl Trop Dis       Date:  2016-01-11

9.  Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families.

Authors:  George W Kasule; David P Kateete; Moses L Joloba
Journal:  BMC Infect Dis       Date:  2016-04-21       Impact factor: 3.090

10.  Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.

Authors:  Leopold D Tientcheu; Mariëlle C Haks; Schadrac C Agbla; Jayne S Sutherland; Ifedayo M Adetifa; Simon Donkor; Edwin Quinten; Mohammed Daramy; Martin Antonio; Beate Kampmann; Tom H M Ottenhoff; Hazel M Dockrell; Martin O Ota
Journal:  PLoS Negl Trop Dis       Date:  2016-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.